DIAGEO PLC financials
Also U.S.-listed. DIAGEO PLC is also a foreign private issuer filing with the U.S. SEC. View its EDGAR financials: DEO — DIAGEO plc
DIAGEO PLC
Country: GB Reporting currency: USD Latest annual report: 2026-06-30
LEI:
213800ZVIELEA55JMJ32 Financial statements
(USD, as reported — unscaled; 114 line items across 3 annual periods)
| Line item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Income statement | |||
| Revenue | $27.76B | $27.96B | $27.89B |
| Cost of sales | $7.96B | $8.07B | $8.07B |
| Gross profit | $11.68B | $12.17B | $12.20B |
| Operating profit (EBIT) | $3.16B | $4.33B | $6.00B |
| Finance costs | $1.20B | $1.25B | $1.28B |
| Profit before tax | $2.56B | $3.54B | $5.46B |
| Income tax expense | $606.0M | $999.0M | $1.29B |
| Profit for the year | $1.96B | $2.54B | $4.17B |
| — attributable to NCI | $221.0M | $184.0M | $296.0M |
| Total comprehensive income | $1.73B | $3.34B | $3.68B |
| Per share | |||
| Basic EPS | $0.78 | $1.06 | $1.73 |
| Diluted EPS | $0.78 | $1.06 | $1.73 |
| Cash flow statement | |||
| Cash generated from operations | $5.96B | $6.21B | $6.07B |
| Net cash from operating activities | $4.39B | $4.30B | $4.11B |
| Income taxes paid | $817.0M | $1.11B | $1.10B |
| Net cash from investing activities | -$982.0M | -$1.72B | -$1.59B |
| Net cash from financing activities | -$3.78B | -$1.49B | -$3.11B |
| Dividends paid | $1.99B | $2.44B | $2.36B |
| Net change in cash | -$374.0M | $1.08B | -$596.0M |
| Balance sheet | |||
| Total assets | $46.84B | $49.32B | — |
| Non-current assets | $29.63B | $31.82B | — |
| Intangible assets & goodwill | $13.38B | $14.78B | — |
| Current assets | $17.21B | $17.50B | — |
| Inventories | $10.53B | $10.66B | — |
| Trade & other receivables | $3.28B | $3.50B | — |
| Cash & equivalents | $1.52B | $2.20B | $1.13B |
| Total equity | $12.95B | $13.18B | $12.07B |
| — attributable to owners | $10.87B | $11.09B | — |
| Non-controlling interests | $2.08B | $2.09B | — |
| Non-current liabilities | $23.16B | $25.43B | — |
| Long-term borrowings | $19.06B | $20.82B | — |
| Current liabilities | $10.73B | $10.71B | — |
| Trade & other payables | $6.42B | $6.95B | — |
| Deferred tax liabilities | $2.46B | $2.94B | — |
| Derived metrics | |||
| Operating margin | 11.4% | 15.5% | 21.5% |
| Net margin | 7.1% | 9.1% | 14.9% |
| Return on equity | 15.1% | 19.3% | 34.5% |
| Cash conversion ratio | 2.24× | 1.69× | 0.99× |
| Other reported items | |||
| Adjusted Weighted Average Shares | 2231.0M | 2228.0M | 2239.0M |
| Adjustments For Decrease Increase In Inventories | -$120.0M | -$470.0M | -$156.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -$129.0M | -$49.0M | -$66.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $2.48B | $1.72B | $493.0M |
| Adjustments For Finance Income Cost | -$816.0M | -$771.0M | -$885.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $71.0M | $22.0M | -$18.0M |
| Bank Overdrafts Classified As Cash Equivalents | $26.0M | $22.0M | $21.0M |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | $364.0M | $342.0M | $203.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | $1.49B | $2.18B | $1.11B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $23.0M | $35.0M | $6.0M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | $345.0M | $147.0M | $156.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | $168.0M | $183.0M | $277.0M |
| Comprehensive Income Attributable To Owners of Parent | $1.56B | $3.16B | $3.40B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | $2.45B | $2.93B | — |
| Current Provisions | $625.0M | $223.0M | — |
| Current Tax Assets Current | $244.0M | $354.0M | — |
| Current Tax Liabilities Current | $207.0M | $138.0M | — |
| Deferred Tax Assets | $173.0M | $150.0M | — |
| Dilutive Effect of Share Options On Number of Ordinary Shares | 7.0M | 6.0M | 5.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | $1.85B | $2.30B | $2.24B |
| Dividends Paid To Noncontrolling Interests | $164.0M | $138.0M | $117.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | $668.0M | — | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | $0.30 | $0.63 | — |
| Dividends Received Classified As Operating Activities | $116.0M | $175.0M | $269.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$18.0M | -$35.0M | -$33.0M |
| Finance Income | $384.0M | $480.0M | $400.0M |
| Gains Losses On Cash Flow Hedges Before Tax | -$47.0M | $298.0M | $13.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | -$406.0M | $1.48B | -$98.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | $50.0M | $103.0M | $111.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -$14.0M | -$7.0M | -$14.0M |
| Increase Decrease In Working Capital | -$76.0M | $77.0M | $768.0M |
| Increase Decrease Through Change In Equity of Subsidiaries | -$26.0M | $2.0M | -$170.0M |
| Increase Decrease Through Sharebased Payment Transactions | $79.0M | $93.0M | $86.0M |
| Increase Decrease Through Treasury Share Transactions | — | $21.0M | -$997.0M |
| Interest Paid Classified As Operating Activities | $1.04B | $980.0M | $1.02B |
| Interest Received Classified As Operating Activities | $292.0M | $181.0M | $156.0M |
| Investment Accounted For Using Equity Method | $5.28B | $5.33B | — |
| Issued Capital | $887.0M | $887.0M | — |
| Liabilities | $33.89B | $36.14B | — |
| Liabilities Included In Disposal Groups Classified As Held For Sale | $681.0M | $193.0M | — |
| Net Assets Liabilities | $12.95B | $13.18B | — |
| Noncurrent Biological Assets | $201.0M | $176.0M | — |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | $21.0M | $39.0M | — |
| Noncurrent Payables | $150.0M | $192.0M | — |
| Noncurrent Provisions | $311.0M | $316.0M | — |
| Noncurrent Recognised Assets Defined Benefit Plan | $1.01B | $1.16B | — |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $387.0M | $409.0M | — |
| Other Adjustments To Reconcile Profit Loss | $62.0M | $37.0M | $88.0M |
| Other Comprehensive Income | -$233.0M | $803.0M | -$485.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | $0 | $0 | -$1.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -$64.0M | -$9.0M | -$75.0M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | $199.0M | -$845.0M | -$70.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -$183.0M | $805.0M | -$423.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -$50.0M | -$2.0M | -$62.0M |
| Other Current Financial Assets | $497.0M | $524.0M | — |
| Other Current Financial Liabilities | $343.0M | $278.0M | — |
| Other Noncurrent Financial Assets | $513.0M | $623.0M | — |
| Other Noncurrent Financial Liabilities | $796.0M | $751.0M | — |
| Other Noncurrent Receivables | $64.0M | $38.0M | — |
| Other Operating Income Expense | -$5.34B | -$4.18B | -$2.51B |
| Other Reserves | -$10.0M | $454.0M | — |
| Proceeds From Current Borrowings | $327.0M | $83.0M | $387.0M |
| Proceeds From Issue of Bonds Notes and Debentures | $1.17B | $3.94B | $2.23B |
| Profit Loss Attributable To Ordinary Equity Holders of Parent Entity | $1.74B | $2.35B | $3.87B |
| Property Plant and Equipment Including Rightofuse Assets | $9.00B | $9.53B | — |
| Purchase of Interests In Investments Accounted For Using Equity Method | $47.0M | $84.0M | $133.0M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -$56.0M | $279.0M | $105.0M |
| Reclassification Adjustments On Exchange Differences On Translation Before Tax | -$86.0M | -$179.0M | -$26.0M |
| Repayments of Bonds Notes and Debentures | $2.82B | $2.42B | $1.67B |
| Repayments of Current Borrowings | $454.0M | $712.0M | $493.0M |
| Retained Earnings | $8.29B | $8.05B | — |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | -$178.0M | $502.0M | -$67.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | $4.0M | $4.0M | $1.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | $218.0M | $193.0M | $414.0M |
| Share Premium | $1.70B | $1.70B | — |
| Weighted Average Shares | 2224.0M | 2222.0M | 2234.0M |
Methodology
Every line item above is a fact tagged in DIAGEO PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.